Please provide your email address to receive an email when new articles are posted on . Semaglutide positively affected renal fat mass, glomerular hemodynamics, inflammation and cortical fibrosis.
The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. Glucagon-like peptide-1 receptor agonists (GLP1-RA) are a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback